CIK 0002124080 · <br>Emerging growth company
Aspen Neuroscience, Inc.
Sign in to watch- Ticker
- ASPE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- EIN
- 831312969
- Phone
- 858.263.1222
- Business address
- 10835 ROAD TO THE CURE, SUITE 100, SAN DIEGO, CA, 92121
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Grant or award Executive Chair acquired 321,672 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
- 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 1,333,333 shares at $15.00 ($19,999,995)
- 4 Open-market buy 10% owner bought 1,200,000 shares at $15.00 ($18,000,000)
- 4 Conversion Director acquired 250,415 shares (conversion)
- 4 Conversion Executive Chair acquired 36,349 shares (conversion)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Bylaws or fiscal year change · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 1 of 2 · 39 filings